Unprecedented benefit seen in test of three-drug treatment for multiple myeloma

In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *